Overview

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas

Status:
Unknown status

Trial end date:
2018-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if additional panretinal photocoagulation of ischemic areas following retinal vein occlusion (RVO) may reduce the rate of recurrence and allow longer treatment intervals in anti-Vascular Endothelial Growth Factor (VEGF) treatment following the "trea-and-extend" scheme.

Phase:

Phase 4

Details

Lead Sponsor:

PD. Dr. med. Armin Wolf

Collaborator:

University Hospital, Bonn

Treatments:

Ranibizumab